Your browser doesn't support javascript.
loading
Suitability of haematopoietic cell donors: updated consensus recommendations from the WBMT standing committee on donor issues.
Worel, Nina; Aljurf, Mahmoud; Anthias, Chloe; Buser, Andreas S; Cody, Meghann; Fechter, Mirjam; Galeano, Sebastian; Greinix, Hildegard T; Kisch, Annika M; Koh, Mickey B C; Mengling, Thilo; Nicoloso, Grazia; Niederwieser, Dietger; Pulsipher, Michael A; Seber, Adriana; Shaw, Bronwen E; Stefanski, Heather E; Switzer, Galen E; Szer, Jeff; van Walraven, Suzanna M; Yang, Hung; Halter, Jörg P.
Afiliação
  • Worel N; Department of Blood Group Serology and Transfusion Medicine, Medical University Vienna, Vienna, 1090, Austria. Electronic address: nina.worel@meduniwien.ac.at.
  • Aljurf M; Oncology Center, King Faisal Specialist Hospital & Research Center, Riyadh, Riyadh Province, Saudi Arabia.
  • Anthias C; Anthony Nolan, London UK; Royal Marsden Hospital, London, UK.
  • Buser AS; Regional Blood Transfusion Service, Swiss Red Cross, Basel, Switzerland; Hematology, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Cody M; National Marrow Donor Program/Be The Match, Minneapolis, MN, USA.
  • Fechter M; Matchis Foundation (the Dutch Centre for Stem Cell Donors), Leiden, the Netherlands.
  • Galeano S; Department of Haematology, Hospital Británico, Montevideo, Uruguay.
  • Greinix HT; Division of Haematology, Medical University Graz, Graz, Austria.
  • Kisch AM; Department of Haematology, Oncology, Radiation Physics, Skane University Hospital, Lund, Sweden; Institute of Health Sciences, Lund University, Sweden.
  • Koh MBC; Infection and Immunity Institute, St George's, University of London, London, UK; Department of Haematology, St George's Hospital, London, UK; Cell Therapy Programme, Health Sciences Authority, Singapore, Singapore.
  • Mengling T; German Bone Marrow Donor Center, Tübingen, Germany.
  • Nicoloso G; Swiss Transfusion Swiss Red Cross, Swiss Blood Stem Cells, Bern, Switzerland.
  • Niederwieser D; Medical Clinic and Policlinic 1, Haematology, Cellular Therapy and Hemostaseology, Leipzig Medical Centre, University Leipzig, Leipzig, Germany.
  • Pulsipher MA; Division of Pediatric Haematology and Oncology, Intermountain Primary Children's Hospital, Huntsman Cancer Institute at the Spencer Fox Eccles School of Medicine at the University of Utah, Salt Lake City, UT, USA.
  • Seber A; Hospital Samaritano and Insituto de Oncologia Pediatrica - Graacc-Unifesp, São Paulo, Brazil.
  • Shaw BE; Center for International Blood and Marrow Transplant Research (CIBMTR), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Stefanski HE; National Marrow Donor Program/Be The Match, Minneapolis, MN, USA.
  • Switzer GE; Departments of Medicine, Psychiatry, and Clinical and Translational Science, University of Pittsburgh, Pittsburgh, PA, USA.
  • Szer J; Department of Clinical Haematology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; The Royal Melbourne Hospital, Melbourne, VIC, Australia.
  • van Walraven SM; Department for Quality and Release Management, Sanquin Blood Bank, Amsterdam, Netherlands.
  • Yang H; Australian Bone Marrow Donor Registry, Sydney, NSW, Australia.
  • Halter JP; Hematology, University Hospital Basel, University of Basel, Basel, Switzerland.
Lancet Haematol ; 9(8): e605-e614, 2022 Aug.
Article em En | MEDLINE | ID: mdl-35901845
The contribution of related donors to the globally rising number of allogeneic haematopoietic stem cell transplantations (HSCT) remains increasingly important, particularly because of the growing use of haploidentical HSCT. Compared with the strict recommendations on the suitability for unrelated donors, criteria for related donors allow for more discretion and vary between centres. In 2015, the donor outcome committee of the Worldwide Network for Blood and Marrow Transplantation (WBMT) proposed consensus recommendations of suitability criteria for paediatric and adult related donors. This Review provides updates and additions to these recommendations from a panel of experts with global representation, including the WBMT, the European Society for Blood and Marrow Transplantation donor outcome committee, the Center for International Blood and Marrow Transplant Research donor health and safety committee, the US National Marrow Donor Program, and the World Marrow Donor Association, after review of the current literature and guidelines. Sections on the suitability of related donors who would not qualify as unrelated donors have been updated. Sections on communicable diseases, clonal haematopoiesis of indeterminate potential, paediatric aspects including psychological issues, and reporting on serious adverse events have been added. The intention of this Review is to support decision making, with the goal of minimising the medical risk to the donor and protecting the recipient from transmissible diseases.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas Tipo de estudo: Guideline / Prognostic_studies Limite: Adult / Child / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas Tipo de estudo: Guideline / Prognostic_studies Limite: Adult / Child / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article